Percutaneous endoscopic gastrostomy with jejunal extension versus direct percutaneous endoscopic jejunostomy: patient-related outcomes and complications Authors: Giel J.L. van Neerven, Eline H.T. Gilissen, Roos Gielen, Arlinda Baars, Bianca M.L. Stelten, Hajo Flink, Lennard P.L. Gilissen Published: 2026 ABSTRACT Background/AimsPercutaneous endoscopic gastrostomy with jejunal extension (PEG-J) and direct percutaneous endoscopic jejunostomy (D-PEJ) are used for jejunal feeding or administration of levodopa-carbidopa intestinal gel in patients with Parkinson’s disease. PEG-J is currently preferred because it is technically less challenging to insert. However, comparative studies are scarce, and data on patient-reported outcomes (PROMs) are limited.MethodsIn this retrospective study conducted at a referral hospital, clinical experience, adverse events (AEs), and PROMs associated with both techniques were evaluated.ResultsNinety-three patients underwent PEG-J and/or D-PEJ placement between January 1, 2010, and July 1, 2022. Patients with PEG-J required significantly more re-endoscopies per tube-year than those with D-PEJ (0.63 [standard deviation, SD, 0.72] vs. 0.27 [SD 0.50]). A total of 76.8% of PEG-J patients underwent at least one re-endoscopy (range, 0–3.85 per year), primarily due to dislocated jejunal extensions (77.4%). Tube-related AEs (including dislocation, occlusion, perforation, and ulceration) occurred significantly more often after PEG-J insertion (76.7% vs. 25.9%). Forty-five patients (48%) completed the PROM questionnaire. No statistically significant differences were found in quality of life. However, D-PEJ patients reported significantly more tube-related pain (44.4% vs. 15.9%).ConclusionsD-PEJ represents a viable alternative to PEG-J in experienced centers and should be considered when frequent complications with jejunal extensions occur. Graphical abstract INTRODUCTION Enteral feeding is most commonly administered via nasogastric or nasoduodenal tubes. For indications lasting longer than 30 days, percutaneous endoscopic gastrostomy (PEG) is the preferred method.1 Jejunal feeding is indicated in cases of gastroparesis, gastric outlet obstruction, intolerance to gastric feeding, altered gastric anatomy, or gastroesophageal reflux associated with a high risk of aspiration pneumonia.1 Medication can also be administered via jejunal access, such as levodopa-carbidopa intestinal gel (LCIG) in patients with advanced Parkinson’s disease.2 Since the introduction of PEG in 1980, jejunal feeding modalities have been developed, including PEG with jejunal extension (PEG-J) in 1984 and direct percutaneous endoscopic jejunostomy (D-PEJ) in 1987.3,4 PEG-J consists of a standard PEG tube with a jejunal extension inserted through the gastric tube lumen and endoscopically positioned in the jejunum. In contrast, D-PEJ involves direct insertion of the same external tube into the jejunum, without an internal extension. Several technical and clinical differences between these approaches warrant consideration. D-PEJ insertion is more complex than PEG-J, as it requires deeper endoscope advancement, often necessitating the use of a pediatric colonoscope.5 The jejunum is narrower and exhibits greater peristaltic activity than the stomach, making safe puncture more technically demanding. One of the few comparative studies—conducted by Zopf et al.6—examined 58 PEG-J and 205 D-PEJ patients and reported first-attempt success rates of 89.7% and 65.4%, respectively. The jejunal extension of PEG-J tubes often leads to complications. Udd et al.7 reported that 38% of 60 patients with Parkinson’s disease experienced PEG-J removal or dislocation during LCIG treatment, necessitating endoscopic reinsertion. Another study described 30 patients who underwent 156 PEG-J reinsertions related to jejunal extension problems over an eleven-year follow-up period.8 According to Zopf et al.,6 D-PEJ was associated with a higher rate of peristomal infections occurring more than seven days after insertion (38.7% vs. 20.6%). Another study found that antibiotic treatment was required in 47% of PEG patients.9 A previously conducted investigation of postprocedural infections showed that two of three D-PEJ patients (67%) developed peristomal infections.10 PEG-Js exhibited significantly more tube occlusions caused by clotting (40.0% vs. 9.9%).6 In the Netherlands, PEG-J is generally preferred because of its lower technical complexity and limited local experience with D-PEJ. Frequent dislocation of PEG-J jejunal extensions requiring re-endoscopy may prompt consideration of alternative techniques such as D-PEJ. Current literature provides limited comparative data between PEG-J and D-PEJ, particularly regarding patient-reported outcome measures (PROMs) and the frequency of re-endoscopies. In recent years, Catharina Hospital Eindhoven (CHE) has gained increasing experience with D-PEJ, primarily in patients with surgically altered anatomy that precludes PEG-J insertion—such as Roux-en-Y reconstructions (gastric bypass, gastrectomy, and pancreatectomy) and esophagectomy. The aim of this study was to compare PEG-J and D-PEJ in a CHE cohort by evaluating re-endoscopy rates, complications, and PROMs. METHODS A retrospective single-center study was conducted at CHE, a Dutch tertiary referral center specializing in PEG-related procedures. Anonymous data collected from electronic patient records (EPR) were analyzed in combination with quality of life (QoL) questionnaires and PROMs. All patients aged over 18 years who underwent PEG-J or D-PEJ placement for feeding or LCIG administration between January 1, 2010, and July 1, 2022, were included. A minimum post-insertion follow-up period of six months was required. Gastrostomy button tubes with jejunal extensions were classified as PEG-J. D-PEJ patients with a button tube were also included. Patients unable to complete the questionnaire (due to death, psychiatric disorders, dementia, or insufficient proficiency in Dutch) were excluded from the survey but remained included in the EPR-based analysis. Data collection was completed on January 1, 2023. Procedure All patients scheduled to undergo an invasive endoscopic intervention were physically examined during a preprocedural consultation with the performing gastroenterologist to discuss the procedure, possible alternatives, and potential risks and complications. The choice between PEG-J and D-PEJ was made through shared decision-making. Insertions were performed according to the following protocols, using conscious sedation with intravenous midazolam and/or fentanyl, followed by observation in the day-care unit for 30–60 minutes before discharge. Antibacterial gauze dressings, but no intravenous antibiotics, were used to prevent wound infections, as previously described.10 1) PEG-J insertion First, a Freka PEG Fr 15 tube (reference 7755643, Fresenius Kabi AG) was placed using the “pull” technique, as previously described.10 After successful PEG insertion, the gastroscope was reintroduced, and a jejunal extension (Freka intestinal tube Fr 9 for PEG Fr 15; reference 7755646, Fresenius Kabi AG) was inserted through the PEG lumen. Using grasping forceps, the extension was endoscopically positioned in the proximal jejunum. It was then attached to the PEG and secured externally with a clamp, completing the PEG-J.11 This procedure typically took approximately 20 minutes. When patients opt for a button-tube, a 14 Fr AMT G-JET gastrojejunal button (Applied Medical Technology Gastric-Jejunal Enteral feeding Tube Inc.) is used. After complete endoscopic PEG-J removal, the fistula tract length is measured. Then, an AMT G-JET with appropriate size is inserted via the gastrostomy, endoscopically positioned in the jejunum with grasping forceps. Finally, the balloon is inflated with 5 mL water. 2) D-PEJ insertion D-PEJ was placed in the proximal jejunum using a pediatric colonoscope inserted orally. The same pull technique as in PEG placement was applied.10 Freka PEG Fr 15 tubes (reference 7755643) were used. Puncturing the jejunal lumen can be challenging because of its small diameter and active peristalsis. In obese patients, transillumination may also be difficult.12 If D-PEJ insertion failed, PEG-J placement was performed during the same session, as described before. The D-PEJ procedure typically took approximately 30–45 minutes. When patients opted to replace the original pull-type D-PEJ tube with a balloon-type button tube, a Freka Belly Button (Fresenius Kabi AG) was inserted after removal of the initial tube. The tube length was determined by measuring the fistula tract with a probe. The endoscopist documented the procedure in the patient’s EPR immediately after insertion. Patients received one standard follow-up telephone consultation two weeks after insertion. In the event of possible complications, patients were instructed to contact either the Endoscopy or Emergency Department. When necessary, a physical examination was performed. All visits and admissions were recorded in the EPR. 3) Questionnaire The questionnaire was written in Dutch and included the EQ-5D-5L to assess QoL, along with specific questions about patient experiences and complications (Supplementary Materials 1, 2).13 At a later stage of the study—unrelated to follow-up duration—the questionnaire was mailed to all patients twice to optimize response rates. Patients completed the questionnaire voluntarily and anonymously. Data collection All EPR data were collected by a single gastroenterologist (L.G.). Questionnaires were prepared, distributed, and collected by students under supervision. The collected data included baseline characteristics, tube type (PEG-J or D-PEJ), indication, type and severity of complications, re-endoscopy frequency, and extra outpatient clinic contacts (EOCC) or hospital admissions. EOCC were assessed for clinical relevance. All anonymized outcomes, including questionnaire results, were analyzed by three students. Outcome measurements The primary outcome measures were (1) The frequency of re-endoscopy for tube-related problems. To account for in situ time, this frequency was also expressed per tube-year (number of interventions divided by tube-years). Endoscopies performed solely to replace the original pull-type PEG or D-PEJ with button tubes were excluded; (2) Patient satisfaction and QoL. Secondary outcomes included EOCC (beyond the standard fourteen-day follow-up), hospital admissions, adverse events (AEs; complications requiring medical intervention), periprocedural mortality (within 30 days after insertion), late tube-related mortality (more than 30 days after insertion), and patient experiences. AEs were categorized as peristomal (AEs occurring at the insertion site, such as pain at insertion, buried bumper, wound infection, external bleeding, leakage, or hypergranulation) or tube-related (AEs caused by the tube, such as jejunal tube dislocation or release, inner or outer tube perforation, occlusion due to clotting or knotting, or gastrointestinal ulceration). All remaining AEs were classified as “other.” PEG-J and D-PEJ tubes are not routinely replaced unless required due to an AE or at the patient’s request to receive a button tube. However, all button tubes (which contain a balloon) require replacement every six months. These scheduled replacement appointments were not considered complications and were therefore excluded from EOCC and AE analyses. Statistical analysis Statistical analysis was performed with IBM SPSS for Windows ver. 29.0 (IBM Corp.). Mean and standard deviation (SD) were calculated for numerical data. EQ-5D-5L questionnaire results were calculated into value using the Versteegh value set ver. 2.1 (updated in 2021).13 Categorical data were summarized as frequencies and percentages (%). No numerical data were normally distributed, thus Wilcoxon signed-rank test was used to assess difference between techniques. Chi-square and Fisher’s exact tests were used to compare categorical outcomes. To indicate significant difference a two-sided p-value of <0.05 was chosen. To adjust for confounding a multivariate linear regression analysis was conducted (dependent, tube type; independent, re-endoscopy per tube-year; co-variables, age at insertion, tube in situ time in months, EOCC per tube-year, admission per tube-year). Unstandardized coefficient (B-value) and p-values were calculated. Ethical considerations This study was exempted from the Medical Research Involving Human Subjects Act, as determined by the Medical Research Ethics Committee of CHE (W23.025). For the anonymous database, the opt-out procedure was used instead of obtaining informed consent. Patients completed the questionnaire voluntarily and anonymously. The study was conducted in accordance with the Declaration of Helsinki.14 An artificial intelligence program was used solely to reduce word count and enhance clarity (Chat Generative Pre-trained Transformer [ChatGPT] ver. GPT-5.1; OpenAI; date of use: October 8, 2025). All generated content was reviewed and edited by the authors as necessary. RESULTS A total of 93 patients underwent PEG-J or D-PEJ insertion between January 1, 2010, and July 1, 2022. Three patients received both tube types (first PEG-J, followed by D-PEJ), each with a minimum follow-up of six months, and were therefore included in both groups. Of the 32 planned D-PEJ insertions, five failed, resulting in a technical success rate of 84.4%. In these cases, PEG-J placement was performed during the same endoscopy session. One PEG-J placement (1.4%) failed and was followed by percutaneous radiologic gastrostomy insertion, which was later endoscopically converted to a PEG-J. In total, 96 tubes were analyzed in 93 patients: 69 PEG-J tubes (71.9%) and 27 D-PEJ tubes (28.1%). Five PEG-J patients (7.2%) received an AMT G-JET, and one D-PEJ patient (3.7%) received a button tube. Of the 93 included patients, 27 were excluded from the questionnaire: 24 had died, and the remaining three were excluded because of psychiatric disorders or language barriers, resulting in 69 eligible patients. In total, 45 questionnaires were completed, corresponding to a 65% response rate. Baseline characteristics from the EPR analysis and PROM questionnaires are presented in Tables 1 and 2. Data analysis of medical records of all included patients The mean patient age was 60.1 (range, 18-84) years. D-PEJ patients were younger than PEG-J patients, with mean ages of 54.9 (range, 20–80) years and 62.2 (range, 18–84) years, respectively. Tube indications included jejunal feeding in 30 patients (31.3%) and LCIG therapy for Parkinson’s disease in 66 patients (68.8%). Among PEG-J patients, the ratio was 12/57 (17.4%/82.6%), whereas among D-PEJ patients, it was 18/9 (66.7%/33.3%). Indications for jejunal feeding in PEG-J patients included idiopathic gastroparesis (n=4) and postoperative gastroparesis (n=8). In D-PEJ patients, indications were idiopathic gastroparesis (n=4), superior mesenteric artery syndrome (n=2), post-gastric or post-esophageal resection (n=3), conversion from PEG-J (n=3), failed PEG insertion (n=2), and neuromuscular disorder following gastric bypass (n=1). PEG-J patients had a significantly longer follow-up duration than D-PEJ patients (mean, 5.28 years vs. 2.87 years; p<0.001). No AEs occurred during insertion. Postprocedural AEs occurred in 78 patients (81.3%), including 57 PEG-J patients (82.6%) and 21 D-PEJ patients (77.8%) (p=0.574). AE subtypes are presented in Table 3. 1) Re-endoscopy Re-endoscopy for tube-related problems was required in 53 PEG-J patients (76.8%) and 10 D-PEJ patients (37.0%) (p=0.001). The mean re-endoscopy rate per tube-year was 0.63 (SD, 0.72; range, 0–3.85) for PEG-J and 0.27 (SD, 0.50; range, 0–1.2) for D-PEJ (p=0.001). The mean per-patient rate also differed significantly: 3.01 (SD, 3.12; range, 0–14) for PEG-J vs. 0.48 (SD, 0.70; range, 0–2) for D-PEJ (p<0.001). Overall, 208 re-endoscopies were performed in PEG-J patients, of which 161 (77.4%) were due to jejunal extension dislocation. Twenty procedures (9.6%) were performed for other inner-tube dysfunctions—occlusion (n=5), tube damage (n=3), or other causes (n=12). Eleven procedures (5.3%) were performed for suspected buried bumper syndrome, which was confirmed in eight cases. Six procedures (2.9%) revealed pyloric or duodenal ulcers associated with pain, and ten (4.8%) were related to other AEs, such as skin problems requiring reinsertion (n=3) and vomiting (n=1). Six procedures (2.9%) revealed no relevant findings. Among D-PEJ patients, thirteen re-endoscopies were performed. Indications included reinsertion after tube cutting in two cases (15.4%), spontaneous tube breakage in one (7.7%), malfunction in one (7.7%), pain in two (15.4%), and skin problems in three (23.1%). Four endoscopies (30.8%) showed no relevant findings. Multivariate linear regression revealed significantly poorer outcomes in PEG-J patients regarding re-endoscopy (B=−0.327, p=0.023) and complications (B=0.597, p<0.001) compared with D-PEJ. 2) Postprocedural tube-related extra outpatient clinic contacts (EOCC) Forty-nine PEG-J patients (71.0%) had a total of 294 EOCCs, compared with 20 D-PEJ patients (74.1%) who had 228 visits (p=1.000). The mean EOCC per patient was 4.26 (SD, 5.61) for PEG-J and 8.44 (SD, 8.60) for D-PEJ (p=0.031). EOCC per tube-year was 0.97 (SD, 1.17) for PEG-J and 5.16 (SD, 7.15) for D-PEJ (p=0.002). 3) Hospital admissions related to AEs Ten admissions occurred in eight PEG-J patients (11.6%) compared with thirteen admissions in ten D-PEJ patients (37.0%) (p=0.008). Among PEG-J patients, two admissions (20.0%) were due to ulcer bleeding, two (20.0%) to peritonitis, one (10.0%) to wound infection, one (10.0%) to obstruction, and four (40.0%) to other causes. In D-PEJ patients, four admissions (23.1%) were for pain, two (15.4%) for retrospectively identified perforations during insertion (one gastric and one small bowel loop), one (7.7%) for external bleeding, two (15.4%) for ileus requiring surgery, one (7.7%) for wound infection, one (7.7%) for readmission, one (7.7%) for skin problems, one (7.7%) for feeding problems, and one (7.7%) for tube reinsertion. The mean number of admissions per tube-year was 0.05 (SD, 0.25) for PEG-J and 1.25 (SD, 5.48) for D-PEJ (p=0.004). One D-PEJ patient had two admissions within one month: the first for a small bowel loop perforation requiring surgery and the second for postoperative ileus. The tube was removed two days after insertion, resulting in a disproportionately high 28.6 admissions per tube-year for this patient. When this outlier was excluded, the admission rate for D-PEJ was 0.20 per year. Overall, the mean hospital stay duration was 12.4 days (SD, 13.6). For PEG-J patients, it was 17.4 days (SD, 18.9; cumulative maximum, 48 days), and for D-PEJ patients, it was 8.4 days (SD, 5.5; cumulative maximum, 18 days; p=0.573). 4) Tube-associated mortality No periprocedural mortality occurred. Late tube-related mortality occurred in three patients (3.1%): two PEG-J patients (2.9%) and one D-PEJ patient (3.7%, p=1.000). In PEG-J patients, mortality was caused by duodenal ulcer bleeding five years after insertion in one patient and by duodenal obstruction with ischemia and ulcerative bleeding three years after insertion in another. Both deaths were attributed to mechanical mucosal injury caused by the jejunal tube. The D-PEJ-related death resulted from ileus caused by jejunal torsion around the fistula five years after insertion, despite surgical release. Questionnaire outcomes Patients reported comparable outcomes regarding tube-related pain, hospital visits, and admissions. D-PEJ patients were more frequently satisfied with aftercare than PEG-J patients (93% vs. 76%). The questionnaire results are presented in Table 4 and Supplementary Tables 1–3. All patients rated tube satisfaction on a numerical rating scale (NRS) from 0 to 10. The mean satisfaction score was 7.05 (SD, 1.87; range, 2–9) for PEG-J and 7.00 (SD, 1.20; range, 5–9) for D-PEJ (p=0.438). Twenty-three PEG-J patients (76.7%) reported that the tube met their expectations, compared with 12 D-PEJ patients (100.0%) (p=0.065). Eighty percent of D-PEJ patients indicated they would choose the tube again, compared with 100% of PEG-J patients. The mean recommendation scores (NRS, 0–10) were 6.95 (SD, 2.70) for PEG-J and 6.57 (SD, 1.87) for D-PEJ (p=0.215). QoL, expressed as utility values (maximum=1.000), averaged 0.547 (SD, 0.329) for PEG-J and 0.578 (SD, 0.396) for D-PEJ (p=0.278). QoL improved in 24 PEG-J patients (80.0%) and nine D-PEJ patients (60.0%), worsened in two PEG-J patients (6.7%) and two D-PEJ patients (13.3%), and remained unchanged in one PEG-J patient (3.3%) and three D-PEJ patients (20.0%) (p=0.249). DISCUSSION When comparing the EPR findings of PEG-J and D-PEJ, four notable observations emerged. First, re-endoscopy rates differed significantly between the two techniques. PEG-J patients had a higher re-endoscopy rate of 0.63 per tube-year compared with 0.27 for D-PEJ. At least one re-endoscopy was performed in 76.8% of PEG-J patients (range, 0–3.9) during a mean follow-up of 5.28 years, compared with 37.0% of D-PEJ patients (range, 0–1.2) during 2.87 years of follow-up; notably, 8% of PEG-J patients underwent more than five procedures. Most re-endoscopies were required for internal jejunal tube complications associated with PEG-J, such as dislocation, obstruction, and ulcer formation. This difference is clinically relevant because endoscopy is an invasive, resource-intensive procedure requiring specialized personnel. Our findings align with previous reports; however, re-endoscopy rates expressed per tube-year have not been published before. This metric is important, as longer follow-up periods naturally result in more AEs and re-endoscopies. Simoni et al. reported 156 additional procedures in 30 PEG-J patients over eleven years, corresponding to 0.47 re-endoscopies per tube-year.8 Cococcia et al.15 described 73 PEG-J patients who underwent 215 replacements over a median follow-up of 21 months, corresponding to approximately one re-endoscopy per year (interquartile range, 6–16 months). Approximately 70% had at least one replacement, and 25% underwent six or more. Secondly, differences in AEs were observed between the two techniques. PEG-J patients experienced significantly more tube dislocations than D-PEJ patients, whereas D-PEJ patients reported pain more frequently (44.4% vs. 15.9%). In contrast to previous findings, Zopf et al. reported no significant differences in pain—assessed in both the short term (<7 days) and long term—between D-PEJ (27.8% and 18.0%) and PEG-J (17.0% and 0.0%).6 A meta-analysis by Deliwala et al.16 found a higher, though not statistically significant, rate of tube-related complications in PEG-J (23.6%) compared with D-PEJ (10.8%). However, major AEs occurred significantly more frequently in D-PEJ (5.0%) than in PEG-J (1.3%), while minor AEs did not differ significantly (15.4% vs. 25.0%).16 A significant difference in tube-related AEs in our study favored D-PEJ (25.9% vs. 76.7%). It is important to note that, although our study demonstrated generally higher complication rates, this discrepancy may be attributed to the significantly longer follow-up period compared with the aforementioned meta-analysis (less than one year). A recent cohort study by Krafft et al.17 reported significantly higher rates of tube dislocation (16%) and tube clotting (15%) in PEG-J compared with D-PEJ (0% and 3%, respectively). Our findings were consistent with these results, except for a higher rate of dislocations (56.5%) and a lower rate of clotting (4.3%). Some AEs were specific to one technique. Two D-PEJ patients (7.4%) developed ileus, likely caused by jejunal torsion around the D-PEJ fistula tract. Both AEs led to hospital admission, and one resulted in death. Additionally, two D-PEJ patients (7.4%) experienced perforation due to puncture of an additional small bowel loop or the stomach during insertion; both cases resolved after surgical intervention. These findings reflect the greater technical complexity of D-PEJ insertion, which is attributable to the jejunum’s smaller diameter and increased peristaltic activity. Thirdly, a clinically relevant but underreported complication was observed in seven PEG-J patients (10.1%): ulceration of the pylorus and/or proximal duodenum. All affected patients required hospital admission and endoscopic evaluation, and two developed fatal ulcer bleeding. All were receiving proton pump inhibitor therapy before onset and had PEG-J tubes for LCIG treatment. It can be hypothesized that these ulcers were caused by mechanical irritation from the jejunal extension. Debris on the pigtail tip may have produced traction during peristalsis, leading to mechanical stress or pressure necrosis (decubitus) at the pylorus and/or the inner duodenal curve. This complication has been reported only in isolated case reports involving patients with Parkinson’s disease receiving LCIG therapy.15,18-20 Decubital ulceration should therefore be considered in PEG-J patients presenting with persistent abdominal pain. The ulcer location and the absence of similar findings among D-PEJ patients—despite the use of the same outer tube—suggest that the inner jejunal extension was responsible for this AE. Fourthly, D-PEJ was associated with a higher rate of hospital admissions than PEG-J, primarily due to pain. Although statistically significant, this difference was largely influenced by a single patient who was admitted twice within a short interval. When this patient was excluded, the admission rate decreased to 0.20 per D-PEJ-year from 1.25. The elevated admission rate may reflect the greater technical complexity of D-PEJ insertion and the potentially increased risk of perforation. Tube-related mortality was comparable between the two techniques—2.9% for PEG-J and 3.7% for D-PEJ—and lower than previously reported rates. All deaths occurred several years after tube insertion, corresponding to mortality-to-tube-year ratios of 0.008 and 0.007, respectively. Earlier studies have reported an early mortality rate of approximately 1%,21 whereas Ramai et al.22 documented a rate of 5.2% for both techniques.23 Alternative options, such as surgical jejunostomy, may be considered when PEG-J or D-PEJ placement is indicated. However, a large comparative study demonstrated poorer outcomes for surgical jejunostomy relative to both endoscopic techniques, particularly concerning intestinal perforation and postprocedural infection.22 This study primarily focused on complications associated with both techniques. Notably, a substantial proportion of patients did not experience tube-related problems during follow-up: 16 PEG-J patients (23.2%) required no re-endoscopy, and seven D-PEJ patients (25.9%) had no tube-related AEs. However, this study was not powered to identify predictors of complications that might guide the selection of the most appropriate technique for individual patients. To our knowledge, this is the first study to compare PEG-J and D-PEJ from both the caregiver and patient perspectives, incorporating QoL assessment. EQ-5D-5L scores revealed no significant differences between the two techniques. Overall satisfaction with the tube was comparable, with mean NRS scores of 7.05 for PEG-J and 7.00 for D-PEJ. These moderate ratings likely reflect the overall burden of living with a transabdominal feeding tube, regardless of type. Similarly, recommendation scores were modest—6.88 for PEG-J and 6.73 for D-PEJ. Only one previous study has evaluated patient satisfaction: 67 PEG-J patients receiving LCIG reported a mean satisfaction score of 7.6.23 Some discrepancies were noted in the PROMs. Although 100% of D-PEJ patients stated that the tube met their expectations, compared with 76.7% of PEG-J patients, only 60.0% of D-PEJ patients reported an improvement in QoL vs. 80.0% of PEG-J patients. This contrast may be explained by differences in age distribution—D-PEJ patients tended to be younger—and indication, with PEG-J patients more frequently treated for LCIG administration and D-PEJ patients primarily receiving enteral nutrition. Both groups reported comparable experiences regarding tube-related pain, hospital visits, and admissions, although these findings differed from those in the EPR data. The long interval between tube insertion and questionnaire completion in some patients may have affected the results. This delay likely reduced the number of eligible respondents due to mortality, potentially introducing survivorship bias and overestimation of both techniques’ performance. Nevertheless, as mortality was largely related to underlying disease rather than tube-related causes, this effect on PROMs is expected to be minimal. All PEG-J patients (100%) indicated that they would choose the same tube again. This finding may reflect limited awareness of D-PEJ as an alternative during the early study period; D-PEJ began to be discussed regularly as an option only after 2020. Before that time, it was primarily considered for patients with altered anatomy. When the results of this study are interpreted from a value-based healthcare perspective, D-PEJ appears to provide greater patient value than PEG-J. In value-based care, patient value represents the ratio of PROMs to cost. Although PROMs were comparable between the two techniques, D-PEJ required fewer re-endoscopies, thereby reducing both procedural costs and patient burden. Strong points and limitations This study is the first to report PROMs, including QoL, among PEG-J and D-PEJ patients. The recent study by Krafft et al.17 compared both techniques from a technical standpoint but did not address patient experience. With a longer follow-up period than previous studies, the present study also provides robust data on complications, re-endoscopy frequency, and hospital admission rates. In addition, this study highlights a relatively underrecognized but clinically relevant AE associated with jejunal extensions: gastrointestinal decubitus ulcers. Finally, although the retrospective design has inherent limitations, a notable strength is that all patients who underwent PEG-J and/or D-PEJ insertion were included, with complete follow-up. However, the single-center (monocenter) design limited the sample size and increased data variability. The questionnaire response rate was 65%, which is acceptable for a retrospective study, though a prospective design could improve data completeness and reduce bias. The study covered a long time interval, which may have introduced nonresponse and survivorship bias. Apart from the EQ-5D-5L component, the questionnaire lacked PEG-specific validation, as no standardized tool currently exists. The study cohort presented heterogeneous indications, particularly among patients receiving jejunal feeding. Although this heterogeneity likely did not influence tube-related AEs, it may have affected PROM outcomes. Recommendations for clinical practice D-PEJ represents a reasonable alternative to PEG-J, although it is technically more challenging to insert. D-PEJ results in significantly fewer invasive and costly re-endoscopies, thereby enhancing patient value. D-PEJ should be considered in place of PEG-J when PEG-J extension-related complications occur, such as recurrent dislocation, blockage, or ulceration. It is also the preferred option in patients with altered gastrointestinal anatomy. To optimize the technical success rate of D-PEJ, the following measures should be implemented (1) designate one or two experienced endoscopists per center for training and procedural performance; (2) use deep sedation to ensure relaxation of the abdominal muscles; (3) apply careful patient selection, as transillumination and adequate puncture of the small intestine can be more difficult in obese patients; (4) refer patients to an experienced center when local expertise is limited. These measures would likely have a positive impact on PROM outcomes. Future research Future research should aim to identify predictors of PEG-J extension-related complications to guide optimal technique selection. Patient value and QoL should be evaluated prospectively using validated, procedure-specific instruments at defined time points (for example, before insertion and six months thereafter) to monitor changes over time. In conclusion, D-PEJ patients required significantly fewer re-endoscopies than PEG-J patients while achieving comparable PROMs, indicating a positive effect on patient value. However, D-PEJ was associated with a higher incidence of postprocedural pain. D-PEJ should therefore be considered a suitable alternative to PEG-J, particularly in patients with altered anatomy or recurrent extension-related complications.